Latest Commercialization News

ClearVue Technologies has responded to ASX concerns after its CEO described previous project pipeline announcements as ‘fairy tales,’ affirming prior disclosures were accurate despite some project setbacks.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

FBR Limited invites eligible shareholders to participate in a $1 million Share Purchase Plan at a 23.1% discount, aiming to fund key robotic projects and repay debt.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

Pure Resources reaffirms exceptional metallurgical results at its Garnet Hills Project, achieving garnet grades up to 98% through sustainable processing. The company is now scaling up testing and forging strategic collaborations in the US to unlock downstream rare earth opportunities.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

Adrad Holdings reported an 8.9% rise in FY25 sales revenue to $153.1 million despite a slight dip in EBITDA, while declaring a fully franked dividend and outlining strategic initiatives for FY26.

Kinetiko Energy reports a peak gas flow rate of 370 Mscfd from its optimised drilling at the Brakfontein well 271-KA03PT10, advancing its South African gas project.

360 Capital REIT has reported a significant turnaround with a $1.3 million statutory profit for FY25, alongside reduced distributions and a new long-term investment management agreement. The fund’s portfolio remains stable, supported by improved leasing and ESG upgrades.